Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shutiao Wentang Pinghan decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian). It is currently being evaluated in clinical trials for the treatment of patients with obstructive sleep apnea syndrome (OSAS) and type 2 diabetes mellitus (T2DM), specifically those categorized under the phlegm-dampness-heat syndrome in TCM diagnostics. The decoction is administered orally as an adjunct to standard lifestyle and cardiometabolic therapies. The therapeutic approach aims to regulate metabolic pathways and improve sleep-related respiratory parameters, with ongoing research utilizing metabolomics to further define its mechanism of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shutiao Wentang Pinghan decoction.